Chapter 27 The Application of Transcriptional Profiling in Model Connectivity and Lead Assessment in Drug Discovery

[1]  D. Hoyer,et al.  Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine , 2007, Molecular Psychiatry.

[2]  A. Nanji,et al.  Transcriptional networks in a rat model for nonalcoholic fatty liver disease: a microarray analysis. , 2006, Experimental and molecular pathology.

[3]  R. Snyder,et al.  Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix database. , 2006, Pharmacogenomics.

[4]  T. Hankemeier,et al.  Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials? , 2006, Pharmacogenomics.

[5]  E. Moler,et al.  Development of a Screening Assay for Surrogate Markers of Chk1 Inhibitor-Induced Cell Cycle Release , 2006, Journal of biomolecular screening.

[6]  R. Parenti,et al.  Genomic profiling of cortical neurons following exposure to β-amyloid , 2006 .

[7]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[8]  P. Fort,et al.  Expression Profile of RhoGTPases and RhoGEFs During RANKL‐Stimulated Osteoclastogenesis: Identification of Essential Genes in Osteoclasts , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  Inmar E. Givoni,et al.  Exploring the Mode-of-Action of Bioactive Compounds by Chemical-Genetic Profiling in Yeast , 2006, Cell.

[10]  D. Notterman,et al.  Gene expression profiling changes induced by a novel Gemini Vitamin D derivative during the progression of breast cancer. , 2006, Biochemical pharmacology.

[11]  Marcin Piechota,et al.  Gene expression profiling in the striatum of inbred mouse strains with distinct opioid-related phenotypes , 2006, BMC Genomics.

[12]  Michael McMillian,et al.  Application of genomics in preclinical drug safety evaluation. , 2006, Basic & clinical pharmacology & toxicology.

[13]  O. Yokosuka,et al.  Sequential gene expression changes in cancer cell lines after treatment with the demethylation agent 5‐Aza‐2′‐deoxycytidine , 2006, Cancer.

[14]  Y. Tabuchi,et al.  Genetic networks responsive to sodium butyrate in colonic epithelial cells , 2006, FEBS letters.

[15]  M. Nagai,et al.  Differentially expressed genes in the prostate cancer cell line LNCaP after exposure to androgen and anti-androgen. , 2006, Cancer genetics and cytogenetics.

[16]  O. Sorgenfrei,et al.  Effects of antidepressant treatment on gene expression profile in mouse brain: cell type‐specific transcription profiling using laser microdissection and microarray analysis , 2006, Journal of neurochemistry.

[17]  M. You,et al.  Organ-specific expression profiles of rat mammary gland, liver, and lung tissues treated with targretin, 9-cis retinoic acid, and 4-hydroxyphenylretinamide , 2006, Molecular Cancer Therapeutics.

[18]  Hisashi Yamada,et al.  Analysis of telomerase activity and RNA expression in a patient with acute promyelocytic leukemia treated with all‐trans retinoic acid , 2006, Pediatric blood & cancer.

[19]  Anatoly L. Mayburd,et al.  Ingenuity Network-Assisted Transcription Profiling: Identification of a New Pharmacologic Mechanism for MK886 , 2006, Clinical Cancer Research.

[20]  D. Bol,et al.  Gene expression profiling in the discovery, optimization and development of novel drugs: one universal screening platform. , 2006, Pharmacogenomics.

[21]  H. Müller,et al.  Gene expression profiling reveals that peripheral nerve regeneration is a consequence of both novel injury‐dependent and reactivated developmental processes , 2006, Journal of neurochemistry.

[22]  D. Kuhn,et al.  Gene expression profile of activated microglia under conditions associated with dopamine neuronal damage , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  Johan Rung,et al.  Advances in systems biology: measurement, modeling and representation. , 2006, Current opinion in drug discovery & development.

[24]  M. Roberge,et al.  Yeast as a tool to uncover the cellular targets of drugs , 2006, Biotechnology journal.

[25]  Shiu-Ru Lin,et al.  Fatty acid metabolism pathway play an important role in carcinogenesis of human colorectal cancers by Microarray-Bioinformatics analysis. , 2006, Cancer letters.

[26]  Jesper Tegnér,et al.  Detection of compound mode of action by computational integration of whole-genome measurements and genetic perturbations , 2006, BMC Bioinformatics.

[27]  G. Wong,et al.  Integration of genomic data for pharmacology and toxicology using Internet resources , 2006, SAR and QSAR in environmental research.

[28]  Catherine J. Auger,et al.  Microarray profiling of gene expression patterns in adult male rat brain following acute progesterone treatment , 2006, Brain Research.

[29]  T. Buterin,et al.  Convergent transcriptional profiles induced by endogenous estrogen and distinct xenoestrogens in breast cancer cells. , 2005, Carcinogenesis.

[30]  Patrick A. Cooke,et al.  Molecular Characterization of the Cytotoxic Mechanism of Multiwall Carbon Nanotubes and Nano-onions on Human Skin Fibroblast , 2005 .

[31]  Jan Frank,et al.  Comparative quantification of pharmacodynamic parameters of chiral compounds (RRR- vs. all-rac-alpha tocopherol) by global gene expression profiling. , 2005, Journal of plant physiology.

[32]  R. Parker,et al.  Endoplasmic Reticulum Stress Links Dyslipidemia to Inhibition of Proteasome Activity and Glucose Transport by HIV Protease Inhibitors , 2005, Molecular Pharmacology.

[33]  Stuart L Schreiber,et al.  Using genome-wide transcriptional profiling to elucidate small-molecule mechanism. , 2005, Current opinion in chemical biology.

[34]  C. Tzeng,et al.  Medicinal Herb Extract and a Single-Compound Drug Confer Similar Complex Pharmacogenomic Activities in MCF-7 Cells , 2004, Journal of Biomedical Science.

[35]  L. Babiss,et al.  Toxicogenomics in predictive toxicology in drug development. , 2004, Chemistry & biology.

[36]  R. Thurmond,et al.  Gene-Expression - Based Responses to Drug Treatment. , 2002, Drug news & perspectives.

[37]  D. Lockhart,et al.  Arrays of arrays for high-throughput gene expression profiling. , 2001, Genome research.

[38]  M. Fielden,et al.  The state-of-the-art in predictive toxicogenomics. , 2006, Current opinion in drug discovery & development.

[39]  T. Downey.  Analysis of a multifactor microarray study using Partek genomics solution. , 2006, Methods in enzymology.

[40]  Lee Weng,et al.  Toxicogenomic analysis methods for predictive toxicology. , 2006, Journal of pharmacological and toxicological methods.